Treatment of Intertrigo: Medical Description and Management
Intertrigo should be treated with a combination of moisture reduction, topical antifungals for fungal infections, and appropriate antibiotics for bacterial superinfections, along with addressing underlying predisposing factors to prevent recurrence. 1, 2, 3
Definition and Clinical Presentation
Intertrigo is a superficial inflammatory dermatitis that occurs on two closely opposed skin surfaces due to:
- Moisture accumulation
- Friction between skin folds
- Poor ventilation
- Exacerbation by bodily secretions (sweat, urine, feces)
Physical examination reveals:
- Erythematous patches in skin folds
- Peripheral scaling
- Possible maceration and erosions
- Satellite lesions (suggestive of candidal infection)
Diagnostic Approach
- Clinical diagnosis: Based on characteristic appearance of inflamed skin folds
- Potassium hydroxide (KOH) preparation: To confirm fungal elements, especially Candida
- Bacterial culture: For suspected bacterial superinfection
- Wood lamp examination: May help identify certain bacterial infections (e.g., Corynebacterium)
Treatment Algorithm
1. Primary Management (All Cases)
- Reduce moisture and friction:
2. For Candidal Intertrigo
First-line: Topical azole antifungals 4, 1
- Clotrimazole cream 1% applied 2-3 times daily for 14 days
- Miconazole cream 2% applied 2-3 times daily for 14 days
- Ketoconazole cream 2% applied 2-3 times daily for 14 days
- Continue until 7 days after clinical resolution
Alternative topical options:
For resistant cases:
3. For Bacterial Superinfections
Streptococcal infections:
Corynebacterium infections:
- Oral erythromycin 1
For other bacterial infections:
- Appropriate topical or systemic antibiotics based on culture results
4. For Mixed Infections
- Combination therapy with both antifungal and antibacterial agents may be necessary
Prevention of Recurrence
Address underlying conditions:
Lifestyle modifications:
For recurrent candidal intertrigo:
Special Considerations
HIV-infected patients: May require longer treatment courses and antiretroviral therapy to reduce recurrence risk 4
Monitoring: Evaluate response within 7 days of starting treatment; seek further evaluation if condition worsens, spreads, or if systemic symptoms develop 4
Caution: Avoid irritant antiseptics that may aggravate intertrigo or provoke allergic contact dermatitis 6
Treatment Pitfalls to Avoid
- Failing to address underlying predisposing factors
- Inadequate drying of affected areas
- Premature discontinuation of antifungal therapy
- Missing bacterial superinfection
- Not considering systemic therapy for extensive or resistant cases
- Overlooking the need for maintenance therapy in recurrent cases
By following this comprehensive approach to intertrigo management, focusing on both treatment of the acute condition and prevention of recurrence, patients can achieve significant improvement in symptoms and quality of life.